5.02 USD
+0.11 (+2.24%)
4.91 USD
-0.11 (-2.19%)
ChartMill assigns a Buy % Consensus number of 89% to CLYM. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 9.69. This target is 93.03% above the current price.
- CLYM was analyzed by 13 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about CLYM.
- In the previous month the buy percentage consensus was at a similar level.
- CLYM was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-16 | William Blair | Initiate | Outperform |
| 2025-10-16 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-13 | HC Wainwright & Co. | Initiate | Buy |
| 2025-09-30 | BTIG | Maintains | Buy -> Buy |
| 2025-09-22 | BTIG | Reiterate | Buy -> Buy |
| 2025-08-15 | Baird | Initiate | Outperform |
| 2025-06-06 | Oppenheimer | Initiate | Outperform |
CLIMB BIO INC / CLYM FAQ
Can you provide the average price target for CLIMB BIO INC stock?
13 analysts have analysed CLYM and the average price target is 9.69 USD. This implies a price increase of 93.03% is expected in the next year compared to the current price of 5.02.
How do analysts rate CLIMB BIO INC (CLYM)?
The consensus rating for CLIMB BIO INC (CLYM) is 89.2308 / 100 . This indicates that analysts generally have a positive outlook on the stock.